Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2020 Filed Apr 21, 2020 21:03 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 2,449 | $47.28 | $115,788.72 |
DisclosureSEC source: 0001127602-20-014237 · form4.xml · nonDerivative · entry 4 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 641,124 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.86 to $47.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 21:03 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 5,093 | $46.40 | $236,315.20 |
DisclosureSEC source: 0001127602-20-014237 · form4.xml · nonDerivative · entry 3 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 643,573 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.84 to $46.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 21:03 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 2,500 | $45.50 | $113,750.00 |
DisclosureSEC source: 0001127602-20-014237 · form4.xml · nonDerivative · entry 2 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 648,666 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.76 to $45.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 21:03 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 564 | $44.11 | $24,878.04 |
DisclosureSEC source: 0001127602-20-014237 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 651,166 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.59 to $44.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:57 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 400 | $38.24 | $15,296.00 |
DisclosureSEC source: 0001127602-20-013886 · form4.xml · nonDerivative · entry 5 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,510 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.17 to $38.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:57 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 7,340 | $37.62 | $276,130.80 |
DisclosureSEC source: 0001127602-20-013886 · form4.xml · nonDerivative · entry 4 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,910 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.16 to $38.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:57 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 4,566 | $36.57 | $166,978.62 |
DisclosureSEC source: 0001127602-20-013886 · form4.xml · nonDerivative · entry 3 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230,250 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.14 to $37.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:57 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 1,517 | $35.81 | $54,323.77 |
DisclosureSEC source: 0001127602-20-013886 · form4.xml · nonDerivative · entry 2 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,234,816 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.08 to $36.08 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:57 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 6,177 | $34.24 | $211,500.48 |
DisclosureSEC source: 0001127602-20-013886 · form4.xml · nonDerivative · entry 1 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,236,333 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.74 to $34.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 21:00 UTC |
Andres JuanSee remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 23,403 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001127602-20-013895 · form4.xml · derivative · entry 5 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,322 Underlying: Common Stock · 23,403 shares Expires 2027-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 21:00 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 9,944 | $37.78 | $375,684.32 |
DisclosureSEC source: 0001127602-20-013895 · form4.xml · nonDerivative · entry 4 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.33 to $38.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 21:00 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 8,852 | $36.91 | $326,727.32 |
DisclosureSEC source: 0001127602-20-013895 · form4.xml · nonDerivative · entry 3 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,944 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.32 to $37.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 21:00 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 4,607 | $36.04 | $166,036.28 |
DisclosureSEC source: 0001127602-20-013895 · form4.xml · nonDerivative · entry 2 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,796 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.31 to $36.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 21:00 UTC |
Andres JuanSee remarks
|
Exercise / conversionCommon Stock | 23,403 | $12.21 | $285,750.63 |
DisclosureSEC source: 0001127602-20-013895 · form4.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:51 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
GiftCommon Stock | 2,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013875 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,697,047 F1 · kind: The reported disposition was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:13 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 1,049 | $32.90 | $34,512.10 |
DisclosureSEC source: 0001127602-20-013693 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,540 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.84 to $32.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:13 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 8,951 | $32.33 | $289,385.83 |
DisclosureSEC source: 0001127602-20-013693 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,027,589 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.82 to $32.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:17 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 10,000 | $32.00 | $320,000.00 |
DisclosureSEC source: 0001127602-20-013698 · form4.xml · nonDerivative · entry 1 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,770 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:06 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 3,139 | $32.00 | $100,448.00 |
DisclosureSEC source: 0001127602-20-013686 · form4.xml · nonDerivative · entry 4 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,214,897 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F5 · ownership.nature: These shares are owned directly by Boston Biotech Ventures, LLC ("Boston Biotech"). The reporting person is the majority equity unit holder and the sole managing member of Boston Biotech. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:06 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 6,277 | $32.00 | $200,864.00 |
DisclosureSEC source: 0001127602-20-013686 · form4.xml · nonDerivative · entry 3 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,917,239 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F4 · ownership.nature: These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:06 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 11,046 | $32.00 | $353,472.00 |
DisclosureSEC source: 0001127602-20-013686 · form4.xml · nonDerivative · entry 2 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 651,730 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F2 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 13, 2020 Filed Apr 14, 2020 20:06 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 3,139 | $32.00 | $100,448.00 |
DisclosureSEC source: 0001127602-20-013686 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,699,983 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 20:48 UTC |
Andres JuanSee remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001127602-20-013503 · form4.xml · derivative · entry 3 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860,725 Underlying: Common Stock · 300 shares Expires 2027-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 20:48 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 300 | $35.13 | $10,539.00 |
DisclosureSEC source: 0001127602-20-013503 · form4.xml · nonDerivative · entry 2 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.08 to $35.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 20:48 UTC |
Andres JuanSee remarks
|
Exercise / conversionCommon Stock | 300 | $12.21 | $3,663.00 |
DisclosureSEC source: 0001127602-20-013503 · form4.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 20:10 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 10,000 | $32.81 | $328,100.00 |
DisclosureSEC source: 0001127602-20-013315 · form4.xml · nonDerivative · entry 1 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,770 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 20:07 UTC |
Andres JuanSee remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,697 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001127602-20-013313 · form4.xml · derivative · entry 3 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 861,025 Underlying: Common Stock · 13,697 shares Expires 2027-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 20:07 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 13,697 | $35.09 | $480,627.73 |
DisclosureSEC source: 0001127602-20-013313 · form4.xml · nonDerivative · entry 2 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 20:07 UTC |
Andres JuanSee remarks
|
Exercise / conversionCommon Stock | 13,697 | $12.21 | $167,240.37 |
DisclosureSEC source: 0001127602-20-013313 · form4.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 20:03 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 11,046 | $32.81 | $362,419.26 |
DisclosureSEC source: 0001127602-20-013311 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 662,776 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F2 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:23 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 3,339 | $30.05 | $100,336.95 |
DisclosureSEC source: 0001127602-20-012699 · form4.xml · nonDerivative · entry 3 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,218,036 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F3 · ownership.nature: These shares are owned directly by Boston Biotech Ventures, LLC ("Boston Biotech"). The reporting person is the majority equity unit holder and the sole managing member of Boston Biotech. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:23 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 6,678 | $30.05 | $200,673.90 |
DisclosureSEC source: 0001127602-20-012699 · form4.xml · nonDerivative · entry 2 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,923,516 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F2 · ownership.nature: These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:23 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 3,339 | $30.05 | $100,336.95 |
DisclosureSEC source: 0001127602-20-012699 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,703,122 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 20:13 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 10,000 | $28.37 | $283,700.00 |
DisclosureSEC source: 0001127602-20-012139 · form4.xml · nonDerivative · entry 1 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,770 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 20:34 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 11,046 | $28.37 | $313,375.02 |
DisclosureSEC source: 0001127602-20-012242 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 673,822 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F2 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 20:11 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 200 | $26.89 | $5,378.00 |
DisclosureSEC source: 0001127602-20-011933 · form4.xml · nonDerivative · entry 6 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,036,540 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.76 to $27.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 20:11 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 1,562 | $25.59 | $39,971.58 |
DisclosureSEC source: 0001127602-20-011933 · form4.xml · nonDerivative · entry 5 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,036,740 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.40 to $26.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 20:11 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 3,238 | $24.95 | $80,788.10 |
DisclosureSEC source: 0001127602-20-011933 · form4.xml · nonDerivative · entry 4 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,038,302 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.37 to $25.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 20:11 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 2,124 | $28.81 | $61,192.44 |
DisclosureSEC source: 0001127602-20-011933 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,041,540 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.42 to $29.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 20:11 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 1,603 | $27.74 | $44,467.22 |
DisclosureSEC source: 0001127602-20-011933 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,043,664 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.37 to $28.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 20:11 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 1,273 | $26.72 | $34,014.56 |
DisclosureSEC source: 0001127602-20-011933 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,045,267 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.36 to $27.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 20:13 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 10,000 | $29.13 | $291,300.00 |
DisclosureSEC source: 0001127602-20-011751 · form4.xml · nonDerivative · entry 1 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,770 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 20:12 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 3,537 | $29.13 | $103,032.81 |
DisclosureSEC source: 0001127602-20-011749 · form4.xml · nonDerivative · entry 4 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,221,375 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F5 · ownership.nature: These shares are owned directly by Boston Biotech Ventures, LLC ("Boston Biotech"). The reporting person is the majority equity unit holder and the sole managing member of Boston Biotech. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 20:12 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 7,075 | $29.13 | $206,094.75 |
DisclosureSEC source: 0001127602-20-011749 · form4.xml · nonDerivative · entry 3 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,930,194 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F4 · ownership.nature: These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 20:12 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 11,046 | $29.13 | $321,769.98 |
DisclosureSEC source: 0001127602-20-011749 · form4.xml · nonDerivative · entry 2 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 684,868 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F2 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 20:12 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 3,537 | $29.13 | $103,032.81 |
DisclosureSEC source: 0001127602-20-011749 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,706,461 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 20:50 UTC |
Andres JuanSee remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,281 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001127602-20-011511 · form4.xml · derivative · entry 9 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874,722 Underlying: Common Stock · 15,281 shares Expires 2027-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 20:50 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 8,187 | $31.75 | $259,937.25 |
DisclosureSEC source: 0001127602-20-011511 · form4.xml · nonDerivative · entry 7 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.43 to $32.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 20:50 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 7,094 | $31.06 | $220,339.64 |
DisclosureSEC source: 0001127602-20-011511 · form4.xml · nonDerivative · entry 6 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,187 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.40 to $31.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 20:50 UTC |
Andres JuanSee remarks
|
Exercise / conversionCommon Stock | 15,281 | $12.21 | $186,581.01 |
DisclosureSEC source: 0001127602-20-011511 · form4.xml · nonDerivative · entry 5 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.